UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

Gene therapy, 2002-01, Vol.9 (2), p.127-134

2002

Volltextzugriff (PDF)

Administration of Helper-Dependent Adenoviral Vectors and Sequential Delivery of Different Vector Serotype for Long-Term Liver-Directed Gene Transfer in Baboons

Proceedings of the National Academy of Sciences - PNAS, 1999-10, Vol.96 (22), p.12816-12821

1999

Volltextzugriff (PDF)

TAK, an HIV Tat-Associated Kinase, is a Member of the Cyclin-Dependent Family of Protein Kinases and is Induced by Activation of Peripheral Blood Lymphocytes and Differentiation of Promonocytic Cell Lines

Proceedings of the National Academy of Sciences - PNAS, 1997-11, Vol.94 (23), p.12331-12336

1997

Volltextzugriff (PDF)

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2151-S2152

2017

Volltextzugriff (PDF)

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Molecular therapy, 2001-04, Vol.3 (4), p.536-542

2001

Volltextzugriff (PDF)

Hepatocyte Gene Therapy in a Large Animal: A Neonatal Bovine Model of Citrullinemia

Proceedings of the National Academy of Sciences - PNAS, 1999-03, Vol.96 (7), p.3981-3986

1999

Volltextzugriff (PDF)

Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.195-195

2011

Volltextzugriff (PDF)

Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.138-138

2002

Volltextzugriff (PDF)

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Cancer gene therapy, 2002-05, Vol.9 (5), p.478-481

2002

Volltextzugriff (PDF)

Analysis of the role of 5′ regulatory mutations in the activation of quiescent metallothionein genes after carcinogen treatment

Gene expression, 1991, Vol.1 (3), p.217-221

1991

Volltextzugriff (PDF)

2188

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S314

2006

Volltextzugriff (PDF)

Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (4), p.1008-1017

2001

Volltextzugriff (PDF)

Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4635-4635

2006

Volltextzugriff (PDF)

Radiographic and immunologic responses to adjuvant immunotherapy for malignant gliomas

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2039-2039

2008

Volltextzugriff (PDF)

2188: Long Term Biochemical Outcome of a Phase I-II Trial Evaluating Cytotoxic Immuno-Genetherapy in Combination With IMRT in Newly Diagnosed Prostate Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S314-S314

2006

Volltextzugriff (PDF)

Coinjection strategy for visual identification of transgenic mice

Transgenic research, 1991-12, Vol.1 (1), p.31-37

1991

Volltextzugriff (PDF)

IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2011-11, Vol.13 (suppl_3), p.iii34-iii40

2011

Volltextzugriff (PDF)

2193

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S316-S317

2006

Volltextzugriff (PDF)

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

Journal of the Society for Gynecologic Investigation, 2002-06, Vol.9 (3), p.174-180

2002

Volltextzugriff (PDF)

2193: Long-Term T Cell Activation Following Combined In Situ Gene Therapy and Intensity-Modulated Radiotherapy Compared to Gene Therapy as Mono-Therapy in Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S316-S317

2006

Volltextzugriff (PDF)

Sustained Long-term Immune Responses Following In Situ Gene Therapy Combined with Radiotherapy and Hormonal Therapy in Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S299-S300

2005

Volltextzugriff (PDF)

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4571-4571

2004

Volltextzugriff (PDF)

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4571-4571

2004

Volltextzugriff (PDF)

Late toxicity of a phase I/II trial evaluating combined radiotherapy and in-situ gene-therapy with or without hormonal therapy in the treatment of prostate cancer

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.S275-S275

2003

Volltextzugriff (PDF)

Sensitivity and reproducibility in adenoviral infectious titer determination

Nature medicine, 1997-07, Vol.3 (7), p.808-811

1997

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

Administration of Helper-Dependent Adenoviral Vectors and Sequential Delivery of Different Vector Serotype for Long-Term Liver-Directed Gene Transfer in Baboons

TAK, an HIV Tat-Associated Kinase, is a Member of the Cyclin-Dependent Family of Protein Kinases and is Induced by Activation of Peripheral Blood Lymphocytes and Differentiation of Promonocytic Cell Lines

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Hepatocyte Gene Therapy in a Large Animal: A Neonatal Bovine Model of Citrullinemia

Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer

Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Analysis of the role of 5′ regulatory mutations in the activation of quiescent metallothionein genes after carcinogen treatment

2188

Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model

Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer

Radiographic and immunologic responses to adjuvant immunotherapy for malignant gliomas

2188: Long Term Biochemical Outcome of a Phase I-II Trial Evaluating Cytotoxic Immuno-Genetherapy in Combination With IMRT in Newly Diagnosed Prostate Cancer

Coinjection strategy for visual identification of transgenic mice

IMMUNOTHERAPY

2193

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

2193: Long-Term T Cell Activation Following Combined In Situ Gene Therapy and Intensity-Modulated Radiotherapy Compared to Gene Therapy as Mono-Therapy in Prostate Cancer Patients

Sustained Long-term Immune Responses Following In Situ Gene Therapy Combined with Radiotherapy and Hormonal Therapy in Prostate Cancer Patients

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Late toxicity of a phase I/II trial evaluating combined radiotherapy and in-situ gene-therapy with or without hormonal therapy in the treatment of prostate cancer

Sensitivity and reproducibility in adenoviral infectious titer determination

Aktive Filter

Suchergebnisse filtern